Focus on: Bill Sietsema
Bill Sietsema has 35 years of experience in the pharmaceutical industry and is currently vice president of global regulatory affairs at Caladrius Biosciences. He has also held executive-level regulatory positions with Amgen, Kendle International/INC Research and has taught pharmaceutical sciences at the University of Cincinnati, College of Pharmacy as an adjunct professor. He has authored 24 journal articles, four book chapters, 42 presentations and posters and is an inventor on six patents. He has published six books on regulatory topics, and served as editor of several RAPS publications, including Global Pharmaceutical and Biologics Regulatory Strategy and Risk Management Principles for Devices and Pharmaceuticals.I recently interviewed Bill for the Regulatory Focus series, ‘Focus on…,’ where we talk with regulatory leaders, thinkers and influencers, sharing their thoughts on a range of topics. We also try to get to know these highly accomplished regulatory professionals better on a personal level and learn about what drives them. In our interview, Bill shared his thoughts on what it takes to be a good regulatory professional, the importance of ethics and what else he might see himself doing if he weren’t in regulatory.
Following is an edited transcript of my interview with Bill: